This article was originally published in The Tan Sheet
Expert advisory panel on NSAIDs will meet in Ottawa Aug. 22-23. In preparation for revising NSAID labeling draft guidance and providing advice on other risk management options, panel will hear stakeholder presentations on safety issues the first day and deliberate on questions posed by the Therapeutic Products Directorate on day two...
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."